Literature DB >> 24793544

The long elusive IgM Fc receptor, FcμR.

Hiromi Kubagawa1, Satoshi Oka, Yoshiki Kubagawa, Ikuko Torii, Eiji Takayama, Dong-Won Kang, Dewitt Jones, Naonori Nishida, Toshio Miyawaki, Luigi F Bertoli, Sheila K Sanders, Kazuhito Honjo.   

Abstract

IgM exists as both a monomer on the surface of B cells and a pentamer secreted by plasma cells. Both pre-immune "natural" and antigen-induced "immune" IgM antibodies are important for protective immunity and for immune regulation of autoimmune processes by recognizing pathogens and self-antigens. Effector proteins interacting with the Fc portion of IgM, such as complement and complement receptors, have thus far been proposed but fail to fully account for the IgM-mediated protection and regulation. A major reason for this deficit in our understanding of IgM function seems to be lack of data on a long elusive Fc receptor for IgM (FcμR). We have recently identified a bona fide FcμR in both humans and mice. In this article we briefly review what we have learned so far about FcμR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24793544      PMCID: PMC4160156          DOI: 10.1007/s10875-014-0022-7

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  68 in total

1.  Antigen receptor tail clue.

Authors:  M Reth
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

2.  IgM binding protein expressed by activated B cells.

Authors:  S K Sanders; H Kubagawa; T Suzuki; J L Butler; M D Cooper
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

3.  T cells with Fc receptors for IgA: induction of T alpha cells in vivo and in vitro by purified IgA.

Authors:  R G Hoover; B K Dieckgraefe; R G Lynch
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

4.  The binding of IgM to B lymphocytes. I. Studies of the binding of aggregated IgM to normal and leukemic human B lymphocytes.

Authors:  R A Rudders; J Andersen; J P Howard; R Fried
Journal:  Clin Immunol Immunopathol       Date:  1980-04

5.  Characterization of the receptor for IgM present on human B lymphocytes.

Authors:  G F Burns; J C Cawley; C R Barker
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

6.  Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia.

Authors:  C D Platsoucas; S Kempin; A Karanas; B Clarkson; R A Good; S Gupta
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

7.  Analysis with antiidiotype antibody of a patient with chronic lymphocytic leukemia and a large cell lymphoma (Richter's syndrome).

Authors:  L F Bertoli; H Kubagawa; G V Borzillo; M Mayumi; J T Prchal; J F Kearney; J R Durant; M D Cooper
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

8.  Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.

Authors:  G X Qian; S M Fu; D L Solanki; K R Rai
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

9.  Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison.

Authors:  E L Reinherz; L Moretta; M Roper; J M Breard; M C Mingari; M D Cooper; S F Schlossman
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

10.  Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes.

Authors:  F K Stevenson; T J Hamblin; G T Stevenson; A L Tutt
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  15 in total

1.  Early Detection of Circulating Antigen and IgM-Associated Immune Complexes during Experimental Mycobacterium bovis Infection in Cattle.

Authors:  Konstantin P Lyashchenko; Rena Greenwald; Alina Sikar-Gang; Archana A Sridhara; Ashley Johnathan; Paul Lambotte; Javan Esfandiari; Mayara F Maggioli; Tyler C Thacker; Mitchell V Palmer; W Ray Waters
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

2.  A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.

Authors:  Haoyang Zhuang; Shuhong Han; Yi Li; Deborah Kienhöfer; Pui Lee; Stepan Shumyak; Richard Meyerholz; Krzysztof Rosadzinski; Danielle Rosner; Annie Chan; Yuan Xu; Mark Segal; Eric Sobel; Li-Jun Yang; Markus H Hoffmann; Westley H Reeves
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

3.  Neuropathogenesis of Zika Virus Infection : Potential Roles of Antibody-Mediated Pathology.

Authors:  Ikuo Tsunoda; Seiichi Omura; Fumitaka Sato; Susumu Kusunoki; Mitsugu Fujita; Ah-Mee Park; Faris Hasanovic; Richard Yanagihara; Satoshi Nagata
Journal:  Acta Med Kinki Univ       Date:  2016

Review 4.  Antibody Isotypes for Tumor Immunotherapy.

Authors:  Anna Kretschmer; Ralf Schwanbeck; Thomas Valerius; Thies Rösner
Journal:  Transfus Med Hemother       Date:  2017-09-07       Impact factor: 3.747

Review 5.  Secreted IgM: New tricks for an old molecule.

Authors:  Rebecca Blandino; Nicole Baumgarth
Journal:  J Leukoc Biol       Date:  2019-07-14       Impact factor: 4.962

6.  Agglutinating mouse IgG3 compares favourably with IgMs in typing of the blood group B antigen: Functionality and stability studies.

Authors:  Tomasz Klaus; Monika Bzowska; Małgorzata Kulesza; Agnieszka Martyna Kabat; Małgorzata Jemioła-Rzemińska; Dominik Czaplicki; Krzysztof Makuch; Jarosław Jucha; Alicja Karabasz; Joanna Bereta
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

7.  Glycan-independent binding and internalization of human IgM to FCMR, its cognate cellular receptor.

Authors:  Katy A Lloyd; Jiabin Wang; Britta C Urban; Daniel M Czajkowsky; Richard J Pleass
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

8.  Differences between Human and Mouse IgM Fc Receptor (FcµR).

Authors:  Hiromi Kubagawa; Christopher M Skopnik; Khlowd Al-Qaisi; Rosaleen A Calvert; Kazuhito Honjo; Yoshiki Kubagawa; Ruth Teuber; Pedram Mahmoudi Aliabadi; Philipp Enghard; Andreas Radbruch; Brian J Sutton
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

9.  The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-binding.

Authors:  Wai-Heng Lua; Wei-Li Ling; Joshua Yi Yeo; Jun-Jie Poh; David Philip Lane; Samuel Ken-En Gan
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

Review 10.  Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.

Authors:  Rekha Khandia; Ashok Munjal; Kuldeep Dhama; Kumaragurubaran Karthik; Ruchi Tiwari; Yashpal Singh Malik; Raj Kumar Singh; Wanpen Chaicumpa
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.